CLINICAL_TRIALS
trial_result
· 2023-07-24
Clinical Trial Update: AllerPops Reduce Nasal Symptoms in Adult Volunteers With Allergic Rhinitis [Phase 2]
Summary
Phase 2 trial update suggesting AllerPops reduce nasal symptoms in adults with allergic rhinitis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AllerPops Corp | Conditions: Allergic Rhinitis | Phase 2 | Status: COMPLETED